Local 12: Trial looks at treating pneumonia associated with COVID-19
Study examines anti-viral medication that could help reduce common complication of the coronavirus
A breakthrough trial is looking at a new anti-viral medication that could help reduce one of the most common complications of the COVID-19 coronavirus: pneumonia.
This new trial is one of a handful across the country looking at an antiviral therapy intended to stop the spread of this virus.
A team at the University of Cincinnati is conducting this research. Brett Kissela, MD, senior associate dean of clinical research at the UC College of Medicine and UC Health physician, is featured.
Read more about UC-led clinical trials.
Featured photo/Colleen Kelley/UC Creative + Brand
Related Stories
Ohio ranked No. 1 for business by CNBC
July 10, 2026
Ohio is CNBC’s No. 1 Top State for Business in 2026. The University of Cincinnati helps fuel that success through co-op, innovation, talent development and close collaboration with the state.
UC students organize free health clinic happening July 11-12
July 10, 2026
The University of Cincinnati student chapter of Remote Area Medical is holding its annual free health clinic July 11-12. The clinic is open to adults and children, with no income requirements. Anyone in the area who needs medical, dental or vision care will have a chance to get it for free, with no insurance required.
Is speech-to-text AI really reliable?
July 10, 2026
UC researcher Nelly Elsayed’s study in the International Journal of Medical Informatics reveals key risks in clinical speech-to-text AI and shows why human review is essential.